Detalhe da pesquisa
1.
The BTLA-HVEM axis restricts CAR T cell efficacy in cancer.
Nat Immunol
; 25(6): 1020-1032, 2024 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-38831106
2.
Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells.
Immunity
; 56(10): 2388-2407.e9, 2023 Oct 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37776850
3.
Streamlined measurement of chimeric antigen receptor T-cell concentration, size, viability and two-color phenotyping during manufacturing.
Cytotherapy
; 26(5): 506-511, 2024 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38483365